Locus coeruleus MRI contrast, cerebral perfusion, and plasma Alzheimer's disease biomarkers in older adults
- PMID: 39637519
- PMCID: PMC11781958
- DOI: 10.1016/j.neurobiolaging.2024.11.008
Locus coeruleus MRI contrast, cerebral perfusion, and plasma Alzheimer's disease biomarkers in older adults
Abstract
The locus coeruleus (LC) is among the first brain structures impacted by Alzheimer's disease (AD), and noradrenergic denervation may contribute to early neurovascular dysfunction in AD. Mechanistic links between the LC and cerebral perfusion have been demonstrated in rodents, but there have been no similar studies in aging humans. Community-dwelling older adults with no history of stroke or dementia (N=66) underwent structural (T1-MPRAGE; T1-FSE) and perfusion (resting pCASL) MRI. Plasma AD biomarkers levels were evaluated for Aβ42/40 ratio (n=56) and pTau181 (n=60). Higher rostral LC structural MRI contrast was associated with lower perfusion in entorhinal and limbic regions but higher perfusion in lateral and medial orbitofrontal cortices. Relationships between LC structure and regional cerebral perfusion were attenuated in older adults with higher plasma pTau levels and lower plasma Aβ42/40 ratios. Previously unstudied links between LC structure and cerebral perfusion are detectible in older adults using MRI and are attenuated in those showing greater AD pathophysiologic change, suggesting an uncoupling of LC-cerebral perfusion relationships in older adults with aggregating AD-related pathophysiology.
Keywords: Alzheimer’s disease; cerebral blood flow; locus coeruleus; older adults; plasma biomarkers.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure statement The authors confirm that no conflicts of interest exist.
Similar articles
-
Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.Alzheimers Res Ther. 2024 Apr 30;16(1):94. doi: 10.1186/s13195-024-01459-y. Alzheimers Res Ther. 2024. PMID: 38689358 Free PMC article.
-
Probing locus coeruleus functional network in healthy aging and its association with Alzheimer's disease biomarkers using pupillometry.Alzheimers Res Ther. 2025 Feb 27;17(1):53. doi: 10.1186/s13195-025-01701-1. Alzheimers Res Ther. 2025. PMID: 40016783 Free PMC article.
-
Locus coeruleus integrity correlates with plasma soluble Axl levels in Alzheimer's disease patients.Alzheimers Dement. 2025 Jul;21(7):e70434. doi: 10.1002/alz.70434. Alzheimers Dement. 2025. PMID: 40596706 Free PMC article.
-
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Cochrane Database Syst Rev. 2014. PMID: 24913723 Free PMC article.
-
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2. Cochrane Database Syst Rev. 2017. PMID: 28328043 Free PMC article.
References
-
- Aghakhanyan G, Galgani A, Vergallo A, Lombardo F, Martini N, Baldacci F, Tognoni G, Leo A, Guidoccio F, Siciliano G, Fornai F, Pavese N, Volterrani D, Giorgi FS, 2022. Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer’s Disease: A multimodal neuroimaging study. Neurobiol Aging 122, 12–21. 10.1016/j.neurobiolaging.2022.11.002 - DOI - PubMed
-
- Avants BB, Tustison NJ, Song G, 2009. Advanced normalization tools (ANTS). Insight Journal 2, 1–35.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical